COMMUNIQUÉS West-GlobeNewswire

Vantage Biosciences Doses First Patient in Phase 2 Clinical Study of Oral VX-01 for Non-Proliferative Diabetic Retinopathy
11/04/2025
LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences , a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been [...]
Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals
11/04/2025
www.inbiome.com Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases Molecular [...]
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
11/04/2025
Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) , today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda Medical [...]
Fagron publishes agenda for 2025 annual shareholders meeting
11/04/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to [...]
CARBIOS announces fiscal-year 2024 financial results
11/04/2025
Cash of €109 million on December 31, 2024 PET biorecycling plant in Longlaville: adjusted schedule and confirmed intention for construction resumption once additional financing has been secured Significant progress made [...]
CARBIOS présente ses résultats annuels 2024
11/04/2025
Cash de 109 millions d’euros au 31 décembre 2024 Usine de biorecyclage de PET à Longlaville : calendrier ajusté et volonté confirmée pour une reprise des travaux de construction après obtention des financements [...]
Immuron Travelan® highest sales in history
11/04/2025
Sales Highlights (unaudited): Global Immuron exceeds AUD$5 million in sales in a fiscal year - highest sales in history March 2025 Quarter AUD$1.3 million up 2% on prior year March 2025 Year to Date AUD$5.3 million up [...]
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
10/04/2025
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to [...]
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/04/2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]
Passing of former Chief Executive Officer, Dr. Loressa Cole
10/04/2025
SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE. Loressa was a beloved [...]
Harvard Bioscience Announces CFO Transition
10/04/2025
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. [...]
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
10/04/2025
Industry leaders gather to discuss innovative solutions for accelerating the development of therapeutics BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company [...]
Arcutis Announces Chief Financial Officer Transition
10/04/2025
WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology [...]
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
10/04/2025
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other [...]
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
10/04/2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced [...]
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
10/04/2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025
10/04/2025
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results [...]
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/04/2025
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
10/04/2025
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that [...]

Pages